81309 Pik3ca gene trgt seq alys
Also known as: PIK3CA targeted sequencing, PIK3CA mutation analysis
Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha (PIK3CA) gene targeted sequencing analysis for oncogenic variants.
In Plain Language
Cancer growth pathway genetic test; Tumor mutation detection
Clinical Context
Identifies PIK3CA activating mutations in various solid tumors to predict targeted therapy response and prognosis.
RVU Information
CPT 81309 does not have a physician work RVU assigned by CMS. Reimbursement for this code is determined by payer-specific fee schedules.
Billing & Documentation
Lab and pathology codes require an order from the treating provider with clinical indication. For molecular pathology and genetic testing, document the specific analytes tested and clinical rationale.
How This Code Compares
This code has a work RVU of 0.00, meaning it does not have a physician work component assigned by CMS. In the Pathology & Lab category, 94% of codes share this characteristic.
Specialties
Frequently Asked Questions
What is CPT code 81309?
CPT 81309 (Pik3ca gene trgt seq alys) is a Pathology & Lab code. Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha (PIK3CA) gene targeted sequencing analysis for oncogenic variants.
Who uses CPT code 81309?
CPT 81309 is used by Pathology, Oncology, Genetics. Identifies PIK3CA activating mutations in various solid tumors to predict targeted therapy response and prognosis.
When is CPT 81309 used?
Identifies PIK3CA activating mutations in various solid tumors to predict targeted therapy response and prognosis.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.